Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis

K de Boeck1, E Eggermont, M Smet

  • 1Department of Paediatrics, University Hospital of Leuven, Belgium.

European Journal of Pediatrics
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlating Quality of Life with Point-of-Care Intestinal Ultrasound in Inflammatory Bowel Disease (CUALITY Study).

Acta gastro-enterologica Belgica·2026
Same author

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
Same author

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
Same author

Seven general radiography x-ray detectors with pixel sizes ranging from 175 to 76<i>μ</i>m: technical evaluation with the focus on orthopaedic imaging.

Physics in medicine and biology·2023
Same author

ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same author

Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020

Specific anti-pseudomonal IgA levels decreased after antibiotic treatment in cystic fibrosis (CF) patients. IgA levels correlated with disease severity, suggesting it

Area of Science:

  • Immunology
  • Pulmonology
  • Microbiology

Background:

  • Cystic Fibrosis (CF) patients often experience chronic Pseudomonas aeruginosa colonization.
  • Acute exacerbations of pulmonary infection are common in CF patients with P. aeruginosa.
  • Monitoring immune responses, including specific antibodies, is crucial for managing CF lung infections.

Purpose of the Study:

  • To evaluate the changes in specific anti-Pseudomonas aeruginosa IgG and IgA levels in CF patients after antibiotic treatment.
  • To assess the correlation between specific antibody levels and disease severity markers.

Main Methods:

  • 32 CF patients with acute pulmonary exacerbations and chronic P. aeruginosa colonization were studied.
  • Measurements included specific anti-pseudomonal IgG and IgA, C-reactive protein, white blood cell count, ESR, pulmonary function tests, and chest radiograph scores.

Related Experiment Videos

  • These parameters were assessed before and after a 2-week intravenous course of anti-pseudomonal antibiotics.

    • Main Results:

    • Specific anti-pseudomonal IgA levels significantly decreased post-treatment, while IgG levels did not.
    • Log of anti-pseudomonal IgA showed a strong correlation with disease severity, including chest radiograph score (r=0.57), forced expiratory volume in 1s (r=0.6), and C-reactive protein (r=0.62).
    • Log of anti-pseudomonal IgG did not correlate significantly with these disease severity markers.

    Conclusions:

    • Specific anti-pseudomonal IgA may serve as a more effective biomarker than IgG for monitoring lung infections in CF patients.
    • The close reflection of ongoing endobronchial infection by IgA supports its utility in CF lung disease management.
    • This highlights the importance of specific IgA in understanding and tracking the progression of CF pulmonary pathology.